Enlivex Therapeutics Ltd
(ENLV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,236 | -4,140 | -29,068 | -19,973 | -14,010 |
| Depreciation Amortization | 348 | 188 | 835 | 635 | 421 |
| Accounts payable and accrued liabilities | -524 | -183 | -1,121 | -1,154 | -240 |
| Other Working Capital | -392 | -962 | -1,818 | -2,837 | -2,422 |
| Other Operating Activity | 1,497 | 587 | 7,649 | 5,083 | 3,444 |
| Operating Cash Flow | $-6,307 | $-4,510 | $-23,523 | $-18,246 | $-12,807 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,192 | 4,917 | -25,865 | -29,956 | -34,218 |
| PPE Investments | 112 | 128 | -103 | -147 | -118 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 288 |
| Other Investing Activity | 0 | 53 | 0 | 0 | 0 |
| Investing Cash Flow | $4,304 | $5,098 | $-25,968 | $-30,103 | $-34,048 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,943 | 524 | 360 | 360 | 360 |
| Financing Cash Flow | $4,943 | $524 | $360 | $360 | $360 |
| Beginning Cash Position | 1,226 | 1,226 | 50,357 | 50,357 | 50,357 |
| End Cash Position | 4,166 | 2,338 | 1,226 | 2,368 | 3,862 |
| Net Cash Flow | $2,940 | $1,112 | $-49,131 | $-47,989 | $-46,495 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,307 | -4,510 | -23,523 | -18,246 | -12,807 |
| Capital Expenditure | -59 | -43 | -236 | -229 | -200 |
| Free Cash Flow | -6,366 | -4,553 | -23,759 | -18,475 | -13,007 |